Gidi Benyamini

Director de Operaciones en Notal Vision Ltd. .

Health Services

Perfil

Gidi Benyamini is currently the Chief Operating Officer at Notal Vision Ltd.
He previously worked as the Vice President-Engineering & Manufacturing at LaserComm Ltd.

Cargos activos de Gidi Benyamini

Empresas	Cargo	Inicio
Notal Vision Ltd. Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel.	Director de Operaciones	04/03/2013

Todos los cargos activos de Gidi Benyamini

Antiguos cargos conocidos de Gidi Benyamini.

Empresas	Cargo	Fin
LaserComm Ltd.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Gidi Benyamini.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gidi Benyamini.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Notal Vision Ltd. Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel.	Health Services
LaserComm Ltd.